Evaluation of the Enteroinsular Axis in Cystic Fibrosis

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Genetic
Study Type: Observational
SUMMARY

Cystic fibrosis related diabetes (CFRD) is associated with worse CF-relevant outcomes. The mechanisms underlying CFRD development are not fully understood, but recent evidence suggests Type 2 Diabetes Mellitus (T2DM) mechanisms may be involved and may involve incretins (gut secreted hormones that augment insulin secretion in response to a nutrient load). This study will examine the prevalence of Genome wide association study (GWAS)-implicated T2DM alleles (including TCF7L2) across the spectrum of glucose abnormalities in CF and will use this information to compare incretin and insulin secretion in non-diabetic children and adults with high risk and low risk alleles.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Healthy Volunteers: f
View:

• Subjects age \>2y

• Diagnosis of Cystic Fibrosis

• For subjects\< 18 years, parental/guardian permission (informed consent) and if appropriate, child assent

Locations
United States
Pennsylvania
The Children's Hopsital of Philadelphia
RECRUITING
Philadelphia
The University of Pennsylvania
RECRUITING
Philadelphia
Contact Information
Primary
Rachel Walega
walegar1@chop.edu
267-586-5969
Time Frame
Start Date: 2013-05
Estimated Completion Date: 2026-07
Participants
Target number of participants: 550
Treatments
Patients with Cystic Fibrosis
Blood or saliva sample collection and medical record review.
Related Therapeutic Areas
Sponsors
Leads: Children's Hospital of Philadelphia
Collaborators: University of Pennsylvania

This content was sourced from clinicaltrials.gov